Dr. Tiwari-Pandey is the Director of Clinical Research and Preclinical Development at Medipure. She received her PhD degree in Endocrinology from Central Drug Research Institute, India and held several years of postdoctoral experience from Institut de recherches cliniques de Montréal (IRCM) and University of Ottawa Heart Institute. She acquires expertise in clinical and regulatory affairs (CCRP), and has extensive R&D and Pharma experience. Her therapeutic area of expertise includes Cancer Research, Menopause-related disorders, Hormone Replacement Therapy, Reproductive Sciences, Osteoporotic Bone Loss, Stem Cells & Cardiac Regeneration, and Biomaterials & Drug delivery. She is the Founder and President of CliniCan Health Research, Canada where she is responsible for promoting our business concept as a CRO for cutting edge R&D services, including collaborative and interdisciplinary research between our clients. At Medipure, she leads the clinical studies and pre-clinical development of pharmaceuticals worldwide. This role works to develop networking between Medipure and industry researchers in the public and private sectors locally, nationally, and internationally. She acts as a nexus between Medipure and the physician community, with respect to the research and clinical initiatives for the mutual benefits.
Rakshit D. Kodekalra (Rax) received his PhD in Agricultural Science from Germany with a specialization in Biochemistry and Toxicology. He continued his research as a postdoctoral fellow and research associate at the University of Hawai’i (USA) and Lakehead University (Canada), respectively, before joining the Medipure Pharmaceuticals R&D team.
His decade long research expertise mainly lies in plant/animal biochemistry, phytochemistry, pharmacognosy, nutritional biochemistry, bioanalytical chemistry, product/process development, and quality assurance/quality control (QA/QC). In addition to his current role in bio-analytical R&D, he will also lead the Medipure QA/QC unit to ensure that developed pharmaceutical products are in compliance with applicable regulatory standards.